All PlansCoverageMedium impact
Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus
Blue Cross & Blue Shield of Mississippi·MS · Gastroenterology, General Surgery·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy establishes medical necessity criteria for endoscopic radiofrequency ablation (RFA) and cryoablation procedures for treating Barrett esophagus with high-grade dysplasia. The policy provides detailed background on Barrett esophagus, treatment approaches, and specifies that RFA may be considered medically necessary for Barrett esophagus with high-grade dysplasia.
Action Required
Review current Barrett esophagus cases to ensure documentation supports high-grade dysplasia diagnosis before submitting RFA or cryoablation claims. Verify that provider documentation includes confirmation of dysplasia by expert pathology review when possible, as the policy emphasizes the importance of accurate pathologic diagnosis. Update prior authorization requests to reference this policy number A.2.01.80 when seeking approval for these procedures.